{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-274193","form_type":"8-K","ticker":"OM","cik":"0001484612","company_name":"Outset Medical, Inc.","filed_at":"2025-11-10T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.503559+00:00","generated_at":"2026-05-16T22:20:42.088681+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Outset Medical Q3 revenue $29.4M (+3%); cuts FY 2025 revenue guidance to $115-120M","bullets":["Net loss $17.8M vs $27.9M a year ago; non-GAAP net loss $12M vs $20.2M.","Gross margin expanded to 39.4% (non-GAAP 39.9%) from 34.3% a year ago.","FY 2025 revenue guidance reduced to $115-120M from prior $122-126M.","Cash use improved to <$6M in Q3; total cash $182M at quarter end.","Operating expenses declined 19% YoY to $27.4M; path to profitability focus."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-274193","json":"https://secwatch.observer/filing/0001193125-25-274193.json","markdown":"https://secwatch.observer/filing/0001193125-25-274193.md","text":"https://secwatch.observer/filing/0001193125-25-274193.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1484612/000119312525274193/0001193125-25-274193-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1484612/000119312525274193/om-20251110.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T22:20:42.088681+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}